Approved 505(b)(2) available for in-licensing:
CHP is pleased to announce the availability of an approved 505(b)(2) product in the cardiovascular space. US rights only.
Asset has significant intellectual property rights. This product is ideally suited for a company with a sales force calling on primary care providers and cardiologists.
Samples and inventory, supply and manufacturing agreements are in place.
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/505-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2021-10-26 15:52:272021-10-31 18:41:20505(b)(2) formulation for chemotherapy available in-licensing
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/505-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2021-10-26 15:47:292021-10-31 18:41:41505(b)(2) formulation for schizophrenia available in-licensing
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/505-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2021-08-17 15:44:022021-10-31 18:42:01Approved 505(b)(2) available for in-licensing
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/In-License-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2020-10-10 15:36:022021-10-31 18:07:59Chemotherapy induced nausea and vomiting product available for in-licensing
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/In-License-icon.png
300
300
Jim Usry
https://commercialhealthcarepartners.com/wp-content/uploads/2021/10/CHP-logo-2021_blu-790x350-2.png
Jim Usry2020-09-20 15:05:132021-10-31 18:08:31Schizophrenia asset available for in-licensing